Benzinga | Jul 19, 2021 08:09AM EDT

Akoya Highlights Publication Of MITRE Study In The Journal For ImmunoTherapy Of Cancer

Akoya Biosciences, Inc., (NASDAQ:AKYA) The Spatial Biology Company(r), today announced that the Phenoptics(tm) mIF solution was used in a multi-site study to demonstrate and validate an automated end-to-end workflow that characterizes PD-1/PD-L1 immune checkpoint signaling in tumor tissue samples. The paper titled, "Multi-institutional TSA-amplified Multiplexed Immunofluorescence Reproducibility Evaluation (MITRE Study)," was published in the Journal for ImmunoTherapy of Cancer (JITC) in July 2021. The MITRE results are an important step toward standardizing an automated mIF-based spatial biology workflow that provides the level of performance needed to support clinical trials and that can be applied to clinical testing in the future.